SCHEMBL16497765

SCHEMBL16497765

c1ccc(-c2ccc(-c3nc4cc(-c5ccc6[nH]c(-c7cccnc7)nc6c5)ccc4[nH]3)cn2)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.59
▸ RAB9A P51151 5/20 0.59
▸ KDM4E B2RXH2 4/20 0.59
▸ MAPT P10636 4/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.59
▸ HPGD P15428 3/20 0.59
▸ ALDH1A1 P00352 2/20 0.59
▸ STAT1 P42224 1/20 0.59
▸ LDHA P00338 1/20 0.58
▸ EPHX2 P34913 1/20 0.58
▸ CYP11B1 P15538 1/20 0.52
▸ PKM P14618 3/20 0.50
▸ LMNA P02545 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ METAP2 P50579 3/20 0.49
▸ METAP1 P53582 3/20 0.49
▸ HTT P42858 2/20 0.49
▸ WNT1 P04628 1/20 0.48
▸ TGFBR1 P36897 1/20 0.48
▸ CLK2 P49760 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16497806 0.85 KDM4E (0.51) NPC1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL16499476 0.81 ALDH1A1 (0.65) NPC1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL13866553 0.80 NPC1 (0.74) NPC1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL10351277 0.79 NPC1 (0.68) NPC1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL16498271 0.79 NPC1 (0.63) NPC1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL14837509 0.78 MAPT (0.60) NPC1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL14837956 0.77 QPCT (0.71) NPC1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL10175464 0.77 CYP11B1 (0.79) NPC1RAB9AKDM4EMAPTSMN1; SMN2
SCHEMBL14297289 0.76 CYP2A6 (0.62) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL6509350 0.76 MAPT (0.69) NPC1RAB9AKDM4EMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011151618-A2 COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE SUMMIT CORPORATION PLC (GB) 2011-12-08 — — WO claimed
Send feedback